IRM vs LSTA · P/E 136, rev $6.15B vs rev $1.0M
Iron Mountain Incorporated (IRM) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the IRM and LSTA stock pages for the full models.
Not investment advice.